
Skin Cancer Symptoms And Images
Skin cancer often appears on sun-exposed areas such as the face, chest, arms, and hands. However, it can also develop in other areas.
Different types of skin cancer – such as actinic keratosis, basal cell carcinoma, squamous cell carcinoma, and melanoma – have distinct appearances. Some symptoms include scaly patches, sores that don't heal, shiny bumps, and moles with irregular features.
Regular self-exams and annual check-ups with a doctor, along with sun protection measures, are important for early detection and reducing the risk of skin cancer.
Skin cancer most often develops on areas of your body that get the greatest exposure to the sun's ultraviolet (UV) rays. It's commonly found on your face, chest, arms, and hands. It can affect anyone.
Even if you've never had a sunburn, you're at risk of developing skin cancer. In People of Color, it's often diagnosed at an advanced stage. This could be due to different factors like access to healthcare, delay in detection, or presentation. Because of lack of research, there are limited resources for recognizing darkly pigmented lesions in People of Color.
Skin cancer can also develop on less exposed areas of your body, like:
scalp
ears
lips
neck
under your fingernails
bottoms of your feet
genitals
Skin cancers often appear as a suspicious mole, freckle, or spot. But accompanying symptoms depend on the type of skin cancer.
Actinic keratosis
An actinic keratosis, known as a precancer, is a scaly or crusty lesion. It most commonly appears on various areas of your body:
scalp
face
ears
lips
back of your hands
forearms
shoulders
neck
These areas are most frequently exposed to the sun. These lesions are sometimes so small that they're found by touch instead of sight. They're often raised and may feel like a small patch of sandpaper on your skin. Depending on your skin tone, the lesions may be red, light or dark tan, white, pink, flesh tones, or a combination of colors.
It's important to treat actinic keratosis early. Untreated lesions have up to a 10 percent chance of becoming squamous cell carcinoma.
Basal cell carcinoma
Basal cell carcinoma develops in your basal skin cells. These cells are at the bottom of your epidermis, the outer layer of your skin.
Basal cell carcinoma has several different appearances. It can look like a:
sore that doesn't heal after seven to 10 days
red patch that may itch, hurt, crust, or bleed easily
shiny bump that can be pink, red, or white or brown on lighter skin. If you have darker skin, it can look tan, black, or brown.
pink growth with an elevated border and an indented center
This type of skin cancer also usually appears on the areas of your body most exposed to the sun. Basal cell carcinomas tend to be easy to treat. These growths develop very slowly, making it less likely they'll spread to other organs or invade muscle, bone, or nerves. But you should talk with your doctor if you notice anything new or changes to your skin or if a wound or sore isn't healing.
Squamous cell carcinoma
Squamous cell carcinomas commonly occur on more sun-exposed body parts. They can also appear on the inside of your mouth or on your genitals. It's the most common skin cancer in Black people.
The tumors caused by squamous cell carcinoma can take a variety of forms, including:
scaly, red to burgundy, or flesh-toned patches that bleed
open sores that bleed, crust, and don't heal
tender, raised growths with a center indent that bleeds
a growth that resembles a wart, but crusts and bleeds
Squamous cell carcinoma is also known to may feel tender and cause intense itching, which further irritates and inflames your skin. Scratching these areas of your skin can lead to infections that need to be treated with antibiotics.
Left untreated, squamous cell carcinoma can grow larger. In rare cases, these lesions can spread to lymph nodes and other organs.
Melanoma
While melanoma isn't the most common type of skin cancer, it's the most serious. This type of skin cancer can be found anywhere on your body, even in your eye.
In People of Color, it often occurs in areas that get little sun exposure, usually on the palms of the hands, soles of the feet, and nails. For individuals who have light or fair skin, it can be often found on the trunk or lower legs.
Use the 'ABCDE' method to help determine if a mole or freckle may be melanoma. You'll want to see your doctor if any of these symptoms apply.
A: asymmetrical
If you drew a line down the middle of a healthy mole, both sides would look very similar. Cancerous moles are asymmetrical. This means that one half of a cancerous mole looks very different from the other.
B: border
The edges of a healthy freckle or mole should look smooth and fairly even. Ragged, raised, or notched borders can be a sign of cancer.
C: change in color
A healthy freckle or mole should be a uniform color. Color variation may be caused by cancer. Keep an eye out for different shades of:
tan
brown
black
red
white
blue
D: diameter
A mole or freckle that's larger than 6 millimeters (about the diameter of a pencil eraser) may be a sign of skin cancer.
E: evolving
Take note of any new moles or freckles. You should also look for changes in the color or size of your existing moles.
Treating skin cancer
Most types of skin cancer that are diagnosed in the early stages are treated by removing the lesion. This can be done in several ways:
Cryosurgery. Liquid nitrogen is applied to your growth to freeze it. The growth then falls off or shrinks without any incisions. This method is often used to treat actinic keratosis.
Curettage and electrodesiccation. Your growth is scraped off with an instrument known as a curette. The area is then burned with an electrocautery needle to destroy any remaining skin cancer cells.
Creams. Your doctor may prescribe topical preparations like imiquimod (Aldara, Zyclara) and 5-fluorouracil (Carac, Efudex). You use these creams for several weeks to remove actinic keratosis and superficial basal cell carcinomas.
Excisional surgery. Your growth and the surrounding skin that appears healthy are removed with a scalpel. The healthy skin is then tested for evidence of skin cancer cells. If cancer cells are found, the procedure is repeated.
Cancer that's spread to your lymph nodes or other organs will require more invasive treatments. This may include chemotherapy or surgery. Talk with your doctor about the treatment option that's best for you.
Preventing skin cancer
You can lower your risk of developing skin cancer with these prevention tips:
Use a sunscreen of at least 30 SPF every day. Apply it 30 minutes before going outside.
If you're sweating a lot or swimming, reapply your sunscreen every 2 hours.
Avoid the sun between peak sun hours, which are 10 a.m. to 4 p.m. If you must be outside, wear sunglasses, hats, and light clothing that will cover your skin.
Do a self-examination of your skin at least once a month.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
20 minutes ago
- Yahoo
Johnson & Johnson (JNJ) Adjusts Revenue and EPS Outlook; Stifel Hikes Price Target
Johnson & Johnson (NYSE:JNJ) ranks among the . On July 16, Stifel maintained its Hold rating on Johnson & Johnson (NYSE:JNJ), but increased its price target for the healthcare giant from $155 to $165. The price target increase comes after JNJ revised its outlook, which now predicts adjusted operational revenue growth of roughly 3.5% instead of the 2.5% midpoint estimate that was previously projected. Pixabay/Public Domain Johnson & Johnson (NYSE:JNJ) also raised its outlook for full-year earnings per share from $10.50 to $10.70 to a range of $10.80 to $10.90. The company cited stronger top-line performance, currency effects, and a lower anticipated impact from tariffs for this improvement. From its initial estimate of $400 million, the healthcare company now projects a $200 million tariff impact in 2025. Johnson & Johnson (NYSE:JNJ) is a notable name in the healthcare industry, which includes sub-sectors like pharmaceuticals, medical equipment, and consumer health products. The company is known for creating medications to treat a variety of conditions and diseases, including cancer, diabetes, and HIV/AIDS. While we acknowledge the potential of JNJ as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. Read More: and Disclosure: None. Sign in to access your portfolio


Medscape
21 minutes ago
- Medscape
Claims Data Fail to Accurately Identify MI Types
TOPLINE: Clinical auditing reveals significant misclassification in administrative codes for myocardial infarction (MI), with only 39% of type 1 (T1MI) codes and 72% of type 2 (T2MI) codes for the condition accurately reflecting the true diagnosis, researchers found. Nearly half of patients coded for T1MI had T2MI, whereas 26% of T2MI codes represented myocardial injury. METHODOLOGY: Researchers identified 350 randomly sampled patients with T1MI codes and 350 patients with T2MI codes during inpatient encounters using the International Statistical Classification of Diseases and Related Health Problems-10th Revision. The analysis included patients aged 65 years and older from October 1, 2017, to May 9, 2024, within eight hospitals in the Mass General Brigham system. Using the 4th Universal Definition of MI, the researchers reviewed the clinical encounters to assess evidence of plaque erosion or thrombus vs oxygen demand-supply imbalance. A second physician review was conducted for 146 challenging and 146 nonchallenging cases. TAKEAWAY: Among the 350 patients coded as having had T1MI, clinical adjudication revealed 138 (39%) as correctly diagnosed; 159 (45%) in fact had T2MI, and 35 (10%) had myocardial injury. Of the 350 patients coded as having had T2MI, 251 (72%) were confirmed, four (1%) were found to have T1MI, and 91 (26%) had myocardial injury. A second physician review demonstrated a high degree of agreement with the initial review, with a 94% agreement in nonchallenging cases and 86% in challenging cases. Hospitals equipped with vs without cardiac catheterization laboratories showed significantly lower misclassification rates (43% vs 58%; P = .0298). IN PRACTICE: 'Among individuals assigned a T1MI claims code, nearly one half have T2MI and many others have myocardial injury; fewer than one half have true T1MI,' the researchers reported. 'Our results also confirm and extend previous work showing that among those with T2MI codes, slightly more than one half have true T2MI, with most of the misclassification related to myocardial injury rather than T1MI. This has critically important implications for epidemiology and public policy' related to acute myocardial infarction. SOURCE: The study was led by Andrea Martinez, MD, of the Department of Medicine at Massachusetts General Hospital, Boston. It was published online on July 21 in Journal of the American College of Cardiology. LIMITATIONS: The results may not be generalized to other hospital systems and countries, where patterns of misclassification might differ. The researchers noted external validity assessment across multiple healthcare systems and in countries that have already introduced International Classification of Diseases-11th revision coding would be beneficial. While patterns of misclassification might have changed over time, the analysis was intentionally restricted to the period when codes for both T1MI and T2MI were available. DISCLOSURES: The study received support through a grant to Jason Wasfy from the Massachusetts General Hospital Executive Committee on Research. Individual authors reported receiving other grants and support, including grants from industry. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Yahoo
24 minutes ago
- Yahoo
COVID-19 cases are on the rise in MA, CDC says. What to know about 'Nimbus' strain.
COVID-19 numbers are rising in Massachusetts, and in states across the country. "COVID-19 laboratory percent positivity is increasing nationally," according to the Centers for Disease Control and Prevention (CDC) website. "Emergency department visits for COVID-19 are increasing among young children 0-4 years old," though the CDC noted that emergency room visits are "low" overall. The latest COVID-19 strain is known as "Nimbus." Here's what to know. Are COVID-19 numbers increasing in Massachusetts? The CDC website has evaluated the issue in each state and determined cases in Massachusetts are likely rising. In Massachusetts, there is an 85.8% chance that COVID-19 numbers are increasing, according to the CDC. The Massachusetts Department of Public Health (DPH) reported that as of June 28, there were 377 confirmed cases of COVID and 77 unconfirmed cases. No COVID-19 deaths were reported at the time. The data stops in June because the Massachusetts DPH "ended data collection for the 2024-2025 viral respiratory season on June 28, 2025, and routine updates to their dashboard for the 2025-2026 season will resume later this summer." What is the current COVID-19 strain 'Nimbus?' As of early June, the new strain known as NB.1.8.1, or "Nimbus," made up 37% of COVID-19 cases nationwide. Variant NB.1.8.1 was first detected in China in January 2025 but accounted for about 0% of cases in the United States until May. The World Health Organization added at the time that currently approved COVID-19 vaccines are "expected to remain effective to this variant against symptomatic and severe disease." Virologists describe Nimbus as a 'slightly upgraded' version of its predecessor. While there is no evidence it causes more severe disease, it appears to be highly transmissible. What are the symptoms of Nimbus? Reported symptoms of NB.1.8.1 are similar to other COVID-19 strains, but one distinctive complaint is a severe sore throat, sometimes described as 'razor-blade throat fatigue.' Other symptoms may include: Mild cough Fever Muscle aches Nasal congestion Are vaccines still effective? Health experts say that updated COVID-19 vaccines remain the best protection against severe illness. Vaccination rates vary widely by state, and health officials continue to urge eligible individuals to stay current with their shots. How can people get tested? People can either take an at-home test or they can see their respective doctors. (This story was updated because an earlier version included an inaccuracy.) This article originally appeared on COVID cases on rise in MA, CDC says. What to know about latest strain Solve the daily Crossword